Sensitivity and Specificity of Ultrasonography Using Ovarian-Adnexal Reporting and Data System Classification Versus Pathology Findings for Ovarian Cancer-Reference-Cited by-同舟云学术

Sensitivity and Specificity of Ultrasonography Using Ovarian-Adnexal Reporting and Data System Classification Versus Pathology Findings for Ovarian Cancer

Published:2021-09-01 Issue: Volume: Page:
ISSN:2168-8184
Container-title:Cureus
language:en
Short-container-title:

Author:

Solis Cano Dania Guadalupe,Cervantes Flores Hugo Alberto,De los Santos Farrera Omar,Guzman Martinez Nancy Berenice,Soria Céspedes Danny

Publisher

Cureus, Inc.

Subject

Aerospace Engineering

Reference11 articles.

1. The Global Cancer Observatory (GCO) . (2020). Accessed. April 22, 2021: https://gco.iarc.fr/..

2. Instituto Nacional de Salud Pública [Internet]. Insp.mx. [citado el 22 de abril de;Información S de S,2021

3. O-RADS US risk stratification and management system: a consensus guideline from the ACR ovarian-adnexal reporting and data system committee;Andreotti RF;Radiology,2020

4. GIRADS: método de clasificación de masas anexiales, revisión sistemática y metanálisis. 10 años de experiencia;Rodríguez G. Luis;Rev chil obstet ginecol,2020

5. Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses;Basha MA;Eur Radiol,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses;Journal of Ovarian Research;2023-08-03

2. Systematic Review and Meta-Analysis of O-RADS Ultrasound and O-RADS MRI for Risk Assessment of Ovarian and Adnexal Lesions;American Journal of Roentgenology;2023-07

3. External Validation of the Ovarian-Adnexal Reporting and Data System (O-RADS) Lexicon and the International Ovarian Tumor Analysis 2-Step Strategy to Stratify Ovarian Tumors Into O-RADS Risk Groups;JAMA Oncology;2023-02-01

4. The Ovarian/Adnexal Reporting and Data System for Ultrasound: From Standardized Terminology to Optimal Risk Assessment and Management;Canadian Association of Radiologists Journal;2022-07-13

5. Tissue factor pathway inhibitor 2: A potential diagnostic marker for discriminating benign from malignant ovarian tumors;Journal of Obstetrics and Gynaecology Research;2022-07